Online ISSN: 2515-8260

Keywords : comorbidities

Statistical Analysis on Novel Corona Virus: COVID-19

Vimal Kumar M N; JAYA R; Rubesh C M; Aakash Ram S

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 1, Pages 95-103

A novel coronavirus, 2019nCoV is identified as the root cause for such a deadly outbreak causing respiratory illness. Due to its widespread impact on the global community, stringent measures were implemented to reduce the effect of the outbreak; self-precautionary measures like using face-masks, hand hygiene, and self-quarantine; environmental measures were insisted to follow and also surface cleaning and community measures to prevent the widespread. The pandemic evolved in China towards the end of 2019 and COVID 19 started to spread all over the globe like a typical wildfire capturing over 190 countries. It grows in a human body with common symptoms like common cold leading to respiratory problems and at times even death. The virus grows exponentially. So, based on the symptoms and the activity of the virus various measures have been implemented. The death rate peaked in the USA and Iran at the end of March and due to comorbidities and many medications has helped in cutting down the numbers. The rate of spread did not shoot up in countries like India due to preventive and cautious care and also due to reduced human contact from the countries with incidence or spread of the vector to other countries.